Drug–Drug Coamorphous Systems: Characterization and Physicochemical Properties of Coamorphous Atorvastatin with Carvedilol and Glibenclamide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pharmaceutical Innovation

• Publication date

  2013-10-27

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1007/s12247-013-9162-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous acquisition of the dissolution curves of two active ingredients in a binary pharmaceutical association, employing an on-line circulation system and chemometrics-assistance.

  2013cited by this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cited by this paper
• Emerging trends in the stabilization of amorphous drugs.

  2013influential reference
• Carvedilol

  2013cited by this paper
• Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.

  2013cited by this paper
• Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.

  2013cited by this paper
• Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.

  2013influential reference
• Coamorphous repaglinide-saccharin with enhanced dissolution.

  2013cited by this paper
• Combination therapy to prevent cardiovascular disease: slow progress.

  2013cited by this paper
• Solubility and dissolution rate of a carbamazepine–cinnamic acid cocrystal

  2013cited by this paper
• Preparation of amorphous carvedilol polymeric microparticles for improvement of physicochemical properties

  2012cited by this paper
• In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide.

  2012cited by this paper
• Drug-drug co-crystals

  2012cited by this paper
• Polymorphs, Salts, and Cocrystals: What’s in a Name?

  2012cited by this paper
• Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions.

  2012cited by this paper
• Thermal degradation of amorphous glibenclamide.

  2012cited by this paper
• Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.

  2012cited by this paper
• Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals

  2011influential reference
• Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.

  2011influential reference
• Net analyte signal standard addition method (NASSAM) as a novel spectrofluorimetric and spectrophotometric technique for simultaneous determination, application to assay of melatonin and pyridoxine.

  2010cited by this paper
• Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals

  2010cited by this paper
• Slow progress

  2010cited by this paper
• Solid State Characterization of Commercial Crystalline and Amorphous Atorvastatin Calcium Samples

  2010cited by this paper
• Atorvastatin calcium.

  2010cited by this paper
• Repurposing an old drug for a new use: glybenclamide exerts antiplatelet activity by interacting with the thromboxane A2 receptor

  2010cited by this paper
• Study of the amorphous glibenclamide drug: analysis of the molecular dynamics of quenched and cryomilled material.

  2010cited by this paper
• Micronization of atorvastatin calcium by antisolvent precipitation process.

  2009cited by this paper
• Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

  2009cited by this paper
• Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.

  2008cited by this paper
• Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.

  2008cited by this paper
• Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

  2007cited by this paper
• Development, characterization and stabilization of amorphous form of a low Tg drug

  2006influential reference
• Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention.

  2006cited by this paper
• The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.

  2005cited by this paper
• Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique.

  2005cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Coronary Heart Disease in Patients With Low LDL-Cholesterol: Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors

  2002cited by this paper
• Crystallization Behavior of Taltirelin Polymorphs in a Mixture of Water and Methanol

  2000cited by this paper
• Preparation and characterisation of a new insoluble polymorphic form of glibenclamide.

  2000cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• United States Pharmacopeia

  1955cited by this paper
• The Extra Pharmacopoeia

  1937cited by this paper

• The role of feed pretreatment and thermal stress in the development of griseofulvin/amino acid CAMS by Hot-Melt Extrusion - Structure relaxation and release/permeability evaluation.

  2025cites this paper
• Coamorphous System of Vitamin B2 and Chlorogenic Acid: Enhanced Physicochemical Property and Synergistic Anti-Inflammatory Potential.

  2025cites this paper
• Lumefantrine co-amorphous systems using deoxycholic acid as a co-former: NIR at-line process monitoring by machine learning

  2025cites this paper
• Crystal engineering to improve the physicochemical properties of ketoconazole in the presence of saccharin

  2025cites this paper
• Development and characterization of co-amorphous griseofulvin/L-leucin by modified solvent processing hot-melt extrusion.

  2024cites this paper
• Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs.

  2024cites this paper
• Enhancing Solubility and Dissolution Behavior of Finasteride Using Solid Dispersion Technique by Carrier Screening and the New Preparation Instrument

  2023cites this paper
• Stability of co-Amorphous Solid Dispersions: Physical and Chemical Aspects

  2023cites this paper
• Recent advances in dual-drug co-amorphous systems.

  2023cites this paper
• Co-rotating twin screw process for continuous manufacturing of solid crystal suspension: A promising strategy to enhance the solubility, permeation and oral bioavailability of Carvedilol

  2023cites this paper
• A Review On Stabilization Mechanism Of Amorphous Form Based Drug Delivery System

  2023cites this paper
• Molecular complexes of drug combinations: a review of cocrystals, salts, coamorphous systems and amorphous solid dispersions.

  2023cites this paper
• Diversity of Solid Forms Promoted by Ball Milling: Characterization and Intrinsic Dissolution Studies of Pioglitazone Hydrochloride and Fluvastatin Sodium Drug–Drug Systems

  2023cites this paper
• Ball-Milling Preparation of the Drug–Drug Solid Form of Pioglitazone-Rosuvastatin at Different Molar Ratios: Characterization and Intrinsic Dissolution Rates Evaluation

  2023cites this paper
• Poly (amino acid)s as new co-formers in amorphous solid dispersion.

  2023cites this paper
• Levofloxacin Cocrystal/Salt with Phthalimide and Caffeic Acid as Promising Solid-State Approach to Improve Antimicrobial Efficiency

  2022cites this paper
• Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies

  2021cites this paper
• Sinomenine-phenolic acid coamorphous drug systems: solubilization, sustained release, and improved physical stability.

  2021cites this paper
• Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

  2021cites this paper
• Considerations for the Selection of Co-formers in the Preparation of Co-amorphous Formulations.

  2021cites this paper
• Insights into co-amorphous systems in therapeutic drug delivery.

  2021cites this paper
• Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy

  2021cites this paper
• Predictive Identification of Co-formers in Co-amorphous Systems.

  2020cites this paper
• Analysis of Solid-State Interactions of Ketoprofen-Coformer Binary Mixtures by DSC and Hot Stage Microscopy

  2020cites this paper
• Pharmaceutical Co-Crystals, Salts, and Co-Amorphous Systems: A Novel Opportunity of Hot Melt Extrusion.

  2020cites this paper
• Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.

  2020cites this paper
• Investigation of Potential Amorphisation and Co-Amorphisation Behaviour of the Benzene Di-Carboxylic Acids upon Cryo-Milling

  2019cites this paper
• In situ co‐amorphisation in coated tablets – The combination of carvedilol with aspartic acid during immersion in an acidic medium

  2019cites this paper
• Quantifying API polymorphs in formulations using X‐ray powder diffraction and multivariate standard addition method combined with net analyte signal analysis

  2019cites this paper
• Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles

  2019cites this paper
• Influence of Preparation Methods on Physicochemical and Pharmacokinetic Properties of Co-amorphous Formulations: The Case of Co-amorphous Atorvastatin: Naringin

  2019cites this paper
• Highly Soluble Glimepiride and Irbesartan Co-amorphous Formulation with Potential Application in Combination Therapy

  2019cites this paper
• Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.

  2019cites this paper
• Characterization of solid dispersions of a powerful statin using thermoanalytical techniques

  2019cites this paper
• Amorphous solid dispersion formation via solvent granulation – A case study with ritonavir and lopinavir

  2019cites this paper
• Incorporation of complexation into coamorphous system dramatically enhances dissolution and eliminates gelation of amorphous lurasidone hydrochloride.

  2019cites this paper
• A New Polymorph of Estradiol and its Stability Studies

  2019cites this paper
• Ionic Liquid Forms of Carvedilol: Preparation, Characterization, and Solubility Studies

  2018cites this paper
• In situ co‐amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium – A proof of concept study

  2018cites this paper
• The relevance of co‐amorphous formulations to develop supersaturated dosage forms: In‐vitro, and ex‐vivo investigation of Ritonavir‐Lopinavir co‐amorphous materials

  2018cites this paper
• Amorphous Drugs: Benefits and Challenges

  2018cites this paper
• Physical Instability: A Key Problem of Amorphous Drugs

  2018cites this paper
• Multicomponent Solid Forms: A New Boost to Pharmaceuticals

  2018cites this paper
• Assessment of amorphization behavior of a drug during co-grinding with an amino acid by discrete element method simulation

  2018cites this paper
• Aspartame as a co‐former in co‐amorphous systems

  2018cites this paper
• Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia

  2018cites this paper
• Advances in coamorphous drug delivery systems☆

  2018cites this paper
• Ionic Liquid Forms of Carvedilol: Preparation, Characterization, and Solubility Studies

  2018cites this paper
• Inhibition of Co-Crystallization of Olmesartan Medoxomil and Hydrochlorothiazide for Enhanced Dissolution Rate in Their Fixed Dose Combination

  2018cites this paper
• Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach

  2017cites this paper
• Supersaturating drug delivery systems: The potential of co-amorphous drug formulations.

  2017cites this paper
• Rational excipient selection for co-amorphous formulations

  2017cites this paper
• Solid state properties and drug release behavior of co‐amorphous indomethacin‐arginine tablets coated with Kollicoat® Protect

  2017cites this paper
• Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan

  2017cites this paper
• Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.

  2017cites this paper
• Co amorphous systems: A product development perspective.

  2016cites this paper
• Application of Vibrational Spectroscopy to Study Solid-state Transformations of Pharmaceuticals.

  2016cites this paper
• Recent advances in co-amorphous drug formulations.

  2016cites this paper
• Studying the thermal decomposition of carvedilol by coupled TG-FTIR

  2015cites this paper
• Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying

  2015cites this paper
• Thermodynamic Solubility Profile of Carbamazepine-Cinnamic Acid Cocrystal at Different pH.

  2015cites this paper
• Stabilization of amorphous paracetamol based systems using traditional and novel strategies.

  2014cites this paper
• Characterisation of valsartan and its compatibility with bisoprolol studied by differential scanning calorimetry and solid-state nuclear magnetic resonance

  2014cites this paper
• Co-rotating twin screw process for continuous manufacturing of solid crystal suspension: A promising strategy to enhance the solubility, permeation and oral bioavailability of Carvedilol [version 1; peer review: 1 approved with reservations]

  year unknowncites this paper